Skip to main content

January 2017

 

 

academics

 

Clinical research courses

Career in Central Forensic Science Laboratory as Scientist - UPSC | Ministry of Home Affairs

Union Public Service Commission invites Applications for the following Posts:

Job for M.Pharm, M.S.Pharm at NIPER as Doctoral Fellow

National Institute of Pharmaceutical Education & Research, Kolkata (NIPER-Kolkata) (Established in the year 2007) is a prestigious Educational Institution of National Importance under the aegis of Dept, of Pharmaceuticals, Ministry of Chemical & Fertilizers, Govt, of India, presently housed at the campus of CSIR-IICB, Jadavpur, Kolkata- 700 032.

Applications are invited for walk-in interview in the enclosed prescribed format for the following posts on purely contract basis initially for a period of one year which may be extended or curtailed on the basis of the performance of the candidates and on mutual consent or requirement of the Institute as the case may be.

Post : Post-Doctoral Fellow (02 posts)

Vacancy for Post Doctoral Fellow at ACTREC | walk in

The Tata Memorial Centre (TMC) is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is a autonomous body funded, controlled by the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI). The HBNI is a Deemed University of the Department of Atomic Energy with a mission to develop high quality postgraduate educational programs in science and technology including those related to life and health sciences.

Post : Post-Doctoral Fellow

Renewcell Cosmedica LLP invites Business Associate | 08 posts

Renewcell Cosmedica LLP, is a leading name in the domain of importer, supplier, distributor, wholesaler & trading a comprehensive array of Skin & Hair Care Products and Equipment, incepted in the year 2000. The demand of offered cosmetic & skin care products is high as these have longer shelf life, are skin-friendly in nature, non-toxic and effective. Our skin & hair care equipment are appreciated for their durability, reliable performance and easy handling features. To ensure the presence of aforementioned features, we source these products and equipment form the most trusted vendors of the industry such as Renew cell & Genietree. At our quality control unit, we make these products and equipment pass a quality check so as to ensure their ability to stand tall on the expectations of patrons.

Post: Business Associate - 08 posts

Vacancy for Professor, Associate Professor, Asistant Professor at S.D. College of Pharmacy & Vocational Studies

S.D. College of Pharmacy & Vocational Studies was established in the year 2001, under the aegis of The S.D. College Association. The Institute offers- B.Pharm and M.Pharm in Pharma Chemistry & Pharmacognosy.
The institute is located in a peaceful & Pollution free environment, which has an attractive building comprising of administrative block, Lecture halls, laboratories, Library, Medicinal garden, Lush green lawns & play grounds.
The institute is just 2 Km from main Roadways Bus Stand & 1 Km from Railway Station of Muzaffarnagar.

Working Opportunity for Drug Safety Specialist at Grünenthal

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

Post : Drug Safety Specialist

Job in Icon Clinical Research for the post of Central Monitor

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies ICON enjoys a strong reputation for quality and is focused on staff development.
We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

Post: Central Monitor

Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's biologics license application (BLA) for MYL-1401O, a proposed biosimilar trastuzumab, for filing through the 351(k) pathway. This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers. The anticipated FDA goal date set under the Biosimilar User Fee Act (BsUFA) is Sept. 3, 2017.

Sangamo Therapeutics, Inc. .  the leader in therapeutic genome editing, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. Orphan drug designations are granted to drugs and biologics intended to treat rare diseases. The designation provides incentives to advance development of rare disease drugs and for commercialization of those drugs that progress to approval.

RedHill Biopharma Ltd. announced that RHB-104 has been granted Qualified Infectious Disease Product (QIDP) designation by the U.S. FDA for the treatment of Nontuberculous Mycobacteria (NTM) infections. The QIDP designation was granted under the FDA's Generating Antibiotic Incentives Now (GAIN) Act, which is intended to encourage development of new antibiotic drugs for the treatment of serious or life-threatening infections.